RCE in Sourcecodester Drug Recommendation System
CVE-2026-94016
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.
Vulnerability class: XSS (Cross-Site Scripting)
CVSS v3 metric
CVSS v3 base score 2.4 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N.
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- cna@vuldb.com (technical-description, vdb-entry)
- cna@vuldb.com (signature, permissions-required)
- cna@vuldb.com (third-party-advisory)
- cna@vuldb.com (third-party-advisory)
- cna@vuldb.com (exploit)
- cna@vuldb.com (product)
Frequently asked questions
- What is CVE-2026-94016?
- CVE-2026-94016 is a low-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Cross-site Scripting. CVSS score: 2.4/10. Published 2026-09-20.
- How severe is CVE-2026-94016?
- Low severity. CVSS v3 base score is 2.4 out of 10.